Asia Pacific Departmental Pacs Market
Taille du marché en milliards USD
TCAC : %
Période de prévision |
2024 –2031 |
Taille du marché (année de référence) |
USD 3.19 Billion |
Taille du marché (année de prévision) |
USD 5.19 Billion |
TCAC |
|
Principaux acteurs du marché |
|
Marché des PACS départementaux, par type de produit (PACS traditionnels, PACS spécialisés), composant (logiciel, services, matériel), application (IRM, tomodensitométrie, radiographie numérique, échographie, imagerie nucléaire, C-Arms et autres), niveau d'intégration (PACS intégrés, PACS autonomes), utilisateur final (hôpitaux, chaînes/centres de radiologie, centres de chirurgie ambulatoire et autres), canal de distribution (appels d'offres directs, administrateurs tiers et autres) - Tendances et prévisions de l'industrie jusqu'en 2031.
Analyse et perspectives du marché des PACS départementaux de la région APAC
Le marché des PACS départementaux englobe un segment du secteur des technologies de l'information de santé dédié au stockage, à la récupération, à la gestion et à la distribution des données d'imagerie médicale au sein de services hospitaliers ou de spécialités médicales spécifiques. Les PACS font partie intégrante des flux de travail d'imagerie médicale modernes, permettant aux radiologues, cardiologues, oncologues et autres spécialistes de stocker et d'accéder numériquement à des images diagnostiques telles que des rayons X, des IRM, des tomodensitogrammes et des échographies. Le système remplace l'imagerie traditionnelle sur film, améliorant l'efficacité, la précision et l'accessibilité des données d'imagerie, améliorant ainsi les soins aux patients. Un PACS départemental est conçu pour répondre aux besoins et aux flux de travail uniques de chaque service, comportant souvent des outils et des interfaces spécialisés qui rationalisent le processus d'imagerie pour des pratiques médicales spécifiques. Ces systèmes facilitent l'intégration transparente avec d'autres systèmes d'information hospitaliers (SIH) et dossiers médicaux électroniques (DME), garantissant que les données d'imagerie des patients sont facilement disponibles tout au long du continuum des soins. Le marché des PACS départementaux est stimulé par le volume croissant des procédures d'imagerie médicale, les progrès de la technologie d'imagerie, le besoin d'une précision diagnostique améliorée et la poussée vers la numérisation des soins de santé. En outre, les exigences réglementaires et l’accent mis sur la réduction des coûts des soins de santé favorisent l’adoption des PACS dans les services. Alors que les prestataires de soins de santé continuent de reconnaître la valeur d’une gestion efficace des données d’imagerie et de l’amélioration des résultats pour les patients, le marché des PACS départementaux est sur le point de connaître une croissance significative.
Data Bridge Market Research analyse que le marché départemental des PACS devrait atteindre 5,19 milliards USD d'ici 2031 contre 3,19 milliards USD en 2023, avec un TCAC de 6,3 % au cours de la période de prévision de 2024 à 2031.
Rapport métrique |
Détails |
Période de prévision |
2024 à 2031 |
Année de base |
2023 |
Années historiques |
2022 (personnalisable pour 2016-2021) |
Unités quantitatives |
Chiffre d'affaires en milliards USD |
Segments couverts |
Type de produit (PACS traditionnel, PACS spécialisé), composant (logiciel, services, matériel), application ( imagerie par résonance magnétique (IRM) , tomodensitométrie (TDM), radiographie numérique, échographie, imagerie nucléaire, arceaux en C, autres), niveau d'intégration (PACS intégré, PACS autonome), utilisateur final (hôpital, chaînes/centres de radiologie, centres de chirurgie ambulatoire , autres), canal de distribution (appels d'offres directs, administrateurs tiers et autres) |
Pays couverts |
Chine, Japon, Inde, Corée du Sud, Australie, Taïwan, Singapour, Thaïlande, Indonésie, Malaisie, Philippines, Nouvelle-Zélande, Vietnam, reste de l'Asie-Pacifique |
Acteurs du marché couverts |
FUJIFILM Corporation, GE Healthcare, Koninklijke Philips NV, Agfa-Gevaert Group, Hyland Software Inc., Lexmark International Inc., Mach 7 Technologies Limited, Novarad Enterprise Healthcare Solutions, Reyence, Siemens (Siemens Healthcare Private Limited), Sectra AB, Softneta, SinoVision, TeleRAD Reporting Services Private Limited et Voyager Imaging, entre autres |
Définition du marché
Le marché des PACS départementaux englobe un segment du secteur des technologies de l'information de santé dédié au stockage, à la récupération, à la gestion et à la distribution des données d'imagerie médicale au sein de services hospitaliers ou de spécialités médicales spécifiques. Les PACS font partie intégrante des flux de travail d'imagerie médicale modernes, permettant aux radiologues, cardiologues, oncologues et autres spécialistes de stocker et d'accéder numériquement à des images diagnostiques telles que des rayons X, des IRM, des tomodensitogrammes et des échographies. Le système remplace l'imagerie traditionnelle sur film, améliorant l'efficacité, la précision et l'accessibilité des données d'imagerie, améliorant ainsi les soins aux patients. Un PACS départemental est conçu pour répondre aux besoins et aux flux de travail uniques de chaque service, comportant souvent des outils et des interfaces spécialisés qui rationalisent le processus d'imagerie pour des pratiques médicales spécifiques. Ces systèmes facilitent l'intégration transparente avec d'autres systèmes d'information hospitaliers (SIH) et dossiers médicaux électroniques (DME), garantissant que les données d'imagerie des patients sont facilement disponibles tout au long du continuum des soins. Le marché des PACS départementaux est stimulé par le volume croissant des procédures d'imagerie médicale, les progrès de la technologie d'imagerie, le besoin d'une précision diagnostique améliorée et la poussée vers la numérisation des soins de santé. En outre, les exigences réglementaires et l’accent mis sur la réduction des coûts des soins de santé favorisent l’adoption des PACS dans les services. Alors que les prestataires de soins de santé continuent de reconnaître la valeur d’une gestion efficace des données d’imagerie et de l’amélioration des résultats pour les patients, le marché des PACS départementaux est sur le point de connaître une croissance significative.
Dynamique du marché des PACS départementaux
Cette section traite de la compréhension des moteurs, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :
Conducteur
- Demande croissante de détection précoce des maladies
La demande croissante de détection précoce des maladies stimule considérablement le marché des PACS (Picture Archiving and Communication System) départementaux de la région APAC, principalement parce que la technologie PACS améliore l'efficacité et la précision des processus de diagnostic. La détection précoce des maladies repose souvent sur des techniques d'imagerie avancées, qui génèrent de grandes quantités de données nécessitant un stockage, une récupération et une analyse efficaces. Les systèmes PACS fournissent une solution numérique pour gérer ces données, permettant un accès rapide et facile aux images médicales et aux informations associées. Cette capacité est cruciale pour la détection précoce des maladies, où un diagnostic rapide et précis peut améliorer considérablement les résultats des patients. En outre, la sensibilisation et l'adoption croissantes de mesures de santé préventives dans la région APAC ont conduit à une augmentation des investissements dans les infrastructures de santé, y compris les technologies d'imagerie et les systèmes PACS. Les gouvernements et les organisations de soins de santé accordent la priorité aux programmes de détection précoce pour réduire le fardeau à long terme des maladies chroniques, ce qui renforce encore la demande de solutions PACS robustes. L'intégration de l'intelligence artificielle (IA) et de l'apprentissage automatique (ML) avec les PACS accélère également cette tendance, car ces technologies améliorent l'analyse des images, améliorent la précision du diagnostic et facilitent l'identification précoce des maladies. Par conséquent, l’accent croissant mis sur la détection précoce des maladies propulse l’expansion du marché des PACS départementaux APAC, car les prestataires de soins de santé s’efforcent d’adopter des solutions innovantes pour répondre à la demande croissante d’outils de diagnostic efficaces et efficients.
Par exemple,
- En novembre 2023, selon un article publié dans la revue Radiology Oncology Systems, le PACS a exploré le rôle essentiel des équipements d'imagerie diagnostique dans l'identification des maladies à leurs premiers stades. Les techniques d'imagerie diagnostique telles que les rayons X, les tomodensitogrammes, les tomographies par émission de positons, les IRM et les ultrasons restent les défenseurs de première ligne contre les menaces cachées pour la santé. Elles permettent aux professionnels de la santé de scruter l'intérieur du corps, dévoilant des anomalies, souvent avant l'apparition des symptômes. Dans une étude récente, il a été révélé qu'un diagnostic précoce par imagerie diagnostique entraînait une augmentation d'environ 20 % de l'efficacité des options de traitement du cancer du poumon (American Association for Cancer Research). Le PACS joue un rôle essentiel dans la prévention et le traitement des maladies
- En novembre 2022, selon un article publié dans GE HealthCare, lorsque les patients sont défavorisés et ne parviennent pas à atteindre leur plein potentiel de santé, les inégalités en matière de santé se reflètent dans les différences de durée de vie, de qualité de vie, de taux de maladie, d’invalidité et de décès, de gravité de la maladie et d’accès au traitement. L’incapacité d’accéder à des éléments importants du parcours de soins, tels que l’imagerie médicale, peut avoir un effet dramatique sur les résultats de santé. Des systèmes d’imagerie médicale avancés comme le PACS sont nécessaires pour se concentrer sur le diagnostic précoce des maladies non transmissibles ou chroniques, telles que les maladies cardiovasculaires, les maladies respiratoires chroniques et le diabète. Un diagnostic précoce est nécessaire pour éviter d’autres maladies et des traitements et dépenses erronés.
- En août 2020, selon le rapport publié par EIT Health, de nouvelles technologies de santé telles que le PACS se sont constamment développées à un rythme rapide et ont permis de détecter et de diagnostiquer les maladies à un stade plus précoce. Cette tendance, également connue sous le nom de diagnostic précoce, devrait entraîner des changements importants au sein des systèmes de santé, car la manière dont les maladies sont détectées et traitées est sur le point d'être remodelée. Elle a le potentiel d'améliorer la qualité des soins, de réduire les coûts et de fournir un traitement plus tôt. Réduire les coûts de traitement en aval pour les payeurs et la société, réduire les taux d'hospitalisation et la pression sur les hôpitaux et les cliniciens, prescrire le bon traitement pour un patient, éviter les interventions inutiles
L’accent croissant mis sur la détection précoce des maladies est un moteur important du marché des PACS départementaux de la région Asie-Pacifique, car la technologie PACS rationalise la gestion de vastes données d’imagerie, ce qui est essentiel pour des diagnostics rapides et précis. À mesure que les soins de santé préventifs gagnent du terrain dans la région, les investissements dans les systèmes PACS augmentent, soutenus par l’intégration de l’IA et du ML pour une précision diagnostique accrue. Cette tendance souligne le rôle essentiel des PACS pour répondre à la demande croissante d’outils de diagnostic efficaces, favorisant ainsi la croissance du marché.
Retenue
- Coûts élevés associés à la mise en œuvre de la gestion de l’imagerie médicale
The high costs associated with the implementation of medical imaging management systems, such as PACS (Picture Archiving and Communication Systems), acts as a significant restraint for the APAC Departmental PACS market. These costs encompass not only the initial investment in sophisticated hardware and software but also the ongoing expenses related to system maintenance, upgrades, and training of medical staff. Smaller healthcare facilities and those in developing regions within the APAC market often face budget constraints, making it challenging to allocate sufficient funds for these advanced imaging management solutions. Furthermore, the financial burden of integrating PACS with existing hospital information systems and ensuring data security and compliance with healthcare regulations adds to the overall cost. These economic challenges can deter healthcare providers from adopting PACS technology despite its benefits in enhancing diagnostic accuracy and operational efficiency. As a result, the market growth of PACS in the APAC region may be hindered, particularly in less affluent areas where the high costs of implementation and maintenance present a significant barrier to adoption.
For instance,
- In April 2024, according to an article by Appinventiv, one of the world’s largest IT services providers, the average cost of developing PACS & DICOM medical imaging software varied from USD 30,000 to USD 300,000. This cost was affected by factors such as software complexity, delivery timelines, location of the hired software development firm, compliance with regulatory standards like HIPAA, and the level of expertise required from the development team. This acted as restraint and hindered the growth of the market
- In November 2019, PACS represented a significant investment as it was a separate software application that had to be purchased independently of the existing Vendor Neutral Archive (VNA) and DICOM viewers. During recent developments, PACS came with high costs, which became a significant restraint in the medical device market. Additionally, integrating a VNA into an existing PACS setup could involve substantial additional expenses, further adding to the financial burden and acted as a restraint in the growth of the market
The high costs of implementing medical imaging management systems, including PACS, act as a significant restraint for the APAC Departmental PACS market. These expenses, which cover initial investments, ongoing maintenance, system upgrades, and staff training, can be prohibitive for smaller or budget-constrained healthcare facilities. The financial burden of integrating PACS with existing systems and ensuring regulatory compliance further exacerbates this challenge. As a result, these high costs can limit the adoption of PACS technology, particularly in less affluent regions, and impede market growth.
Opportunity
- Adoption of AI Technology in Imaging
The adoption of AI technology in imaging presents significant opportunities for the APAC Departmental PACS (Picture Archiving and Communication Systems) market by enhancing diagnostic accuracy, efficiency, and workflow automation. AI-powered algorithms can analyze medical images with high precision, assisting radiologists in detecting anomalies, diagnosing conditions, and prioritizing urgent cases more effectively. This integration streamlines the imaging process, reducing the time required for image analysis and interpretation, which is crucial in high-volume settings. AI enhances the functionality of PACS systems by enabling advanced features such as automated image segmentation, predictive analytics, and decision support tools, which improve overall clinical outcomes. As healthcare providers in the APAC region increasingly seek to leverage AI to manage the growing volume of medical images and optimize diagnostic workflows, the demand for PACS systems that incorporate these advanced technologies is expected to rise. This shift not only positions PACS systems as integral components of modern healthcare infrastructure but also opens up new avenues for innovation and market growth in the APAC region.
For instance,
- In June 2024, according to news report published by MIT news, mentioning that Artificial intelligence and PACS often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. These models have also been shown to develop some surprising abilities. In 2022, MIT researchers reported that AI models will expect to make accurate predictions about a patient’s race from their chest X-rays. Their research team has now found that the models that are most accurate at making demographic predictions
- In June 2024, according to news report published by MIT news, reporting that as of May 2024, the FDA has approved 882 AI-enabled medical devices, with 671 of them designed to be used in radiology. Since 2022, when Ghassemi and her colleagues showed that these diagnostic models can accurately predict race, they and other researchers have shown that such models are also very good at predicting gender and age, even though the models are not trained on those tasks
- In March 2024, according to an article published by Elsevier, highlighting about the AI domains such as enhanced image analysis, operational efficiency, predictive and personalized healthcare, and clinical decision support in diagnostic imaging. Concluded that AI is revolutionizing diagnostic imaging by improving accuracy, efficiency, and personalized healthcare delivery
- In April 2024, according to an article published by Elsevier, aimed at mapping the available technology instruments to improve access to imaging at primary health care; to identify the facilitators and barriers, and the knowledge gaps for widespread adaptation of technology solutions. Suggests that teleradiology when combined with AI and mobile digital imaging units can address radiologist shortages; strengthen programs aimed at population screening and emergency care
The adoption of AI technology in imaging creates substantial opportunities for the APAC Departmental PACS market by enhancing diagnostic accuracy and workflow efficiency. AI enables advanced features like automated image analysis and predictive analytics, which streamline the imaging process and improve clinical outcomes. As healthcare providers in APAC increasingly integrate AI to handle growing imaging demands, the need for advanced PACS systems is expected to rise, driving market growth and innovation.
Challenge
- Data Security and Privacy Concerns due to Technical Complexity
Picture Archiving and Communication Systems (PACS) are sophisticated technologies that require advanced IT expertise for installation, configuration, and maintenance. The technical demands associated with these systems can lead to substantial operational costs and resource allocation challenges. Ensuring system reliability and minimizing downtime is essential, as disruptions such as system failures, data loss, or software glitches can delay access to critical medical images, which in turn affects diagnostic accuracy and treatment timeliness. The necessity for specialized IT support for troubleshooting and ongoing system updates further complicates and increases the cost of maintaining these systems.
For instance,
- In December 2020, according to an article published by NIST, securing PACS was challenging due to the varied medical imaging needs across different departments within healthcare organizations (HDOs) and the use of multiple PACS or archiving systems. Additionally, external imaging specialists were involved, and diverse clinical users accessed PACS from different locations, creating a complex environment that increased cybersecurity risks
- This complexity posed a challenge for the Asia Pacific Departmental PACS market by making it difficult to ensure robust cybersecurity measures across a fragmented and widely accessed PACS ecosystem
- According to an article published by Open MedScience, PACS systems depends on complex technology, which can lead to issues such as system failures, data loss, and software glitches, causing downtime and delays in patient care. Additionally, PACS requires specialized and often costly training for radiology staff, with ongoing updates needed to keep pace with technological advancements. This challenge impacts the Asia Pacific Departmental PACS Market by increasing operational costs and potentially disrupting patient care due to technical issues and the need for continuous staff training
The technical complexity heightens concerns about data security and privacy, as managing and protecting sensitive medical information across diverse and intricate systems can be particularly challenging, impacting the overall efficiency and security of healthcare facilities.
Recent Developments
- In January 2024, FUJIFILM Diosynth Biotechnologies and SHL Medical entered strategic partnership agreement to help meet growing market demand for autoinjector medicines. The partnership, part of SHL’s Alliance Management Program, aimed to streamline processes and enhance efficiency for pharmaceutical and biotech companies offering self-injection device finished goods services primarily with SHL’s flagship platform Molly
- In August 2022, the Agfa-Gevaert Group signed a share purchase agreement with AURELIUS Group for the sale of its Offset Solutions division within the framework of its ongoing transformation process. The sales enabled the Group to increase the focus on its growth businesses
Departmental PACS Market Scope
The departmental PACS market is segmented into six notable segments based on Product Type, Component, Application, Integration Level, End User, Distribution Channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
By Product Type (Traditional PACS, Specialty PACS), Component (Software, Services, Hardware), Application (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Digital Radiography, Ultrasound, Nuclear Imaging, C-Arms, Others), Integration Level (Integrated PACS, Standalone PACS), End User (Hospital, Radiology Chains/Centers, Ambulatory Surgery Centers, Others), Distribution Channel (Direct Tenders, Third Party Administrators, Others)
Product Type
- Traditional PACS
- Specialty PACS
On the basis of product type, the market is segmented into traditional PACS, and speciality PACS.
Component
- Software
- Services
- Hardware
On the basis of component, the market is segmented into software, services, and hardware.
Application
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Digital Radiography
- Ultrasound
- Nuclear Imaging
- C-Arms
- Others
On the basis of application, the market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), digital radiography, ultrasound, nuclear imaging, c-arms, and others.
Integration Level
- Integrated PACS
- Standalone PACS
On the basis of integration level, the market is segmented into integrated PACS, and standalone PACS.
End User
- Hospitals
- Radiology Chains/Centers,
- Ambulatory Surgical Centers
- Others
On the basis of end user, the market is segmented into hospitals, radiology chains/centers, ambulatory surgical centers, and others.
Distribution Channel
- Direct Tenders
- Third Party Administrators
- Others
On the basis of distribution channel, the market is segmented into direct tenders, third party administrators, and others.
Departmental PACS Market Regional Analysis/Insights
The departmental PACS market is segmented into nine notable segments based on Product Type, Component, Application, Integration Level, End User, and Distribution Channel.
The countries covered in this market report are China, Japan, India, South Korea, Australia, Taiwan, Singapore, Thailand, Indonesia, Malaysia, Philippines, New Zealand, Vietnam, rest of Asia-Pacific.
Japan is growing in the APAC departmental PACS market and is expected to dominate the market with an increasing prevalence of chronic disorders in the country.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and APAC Departmental PACS Market Share Analysis
The departmental PACS market competitive landscape provides details of competitors. Details included are compmarketany overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players are FUJIFILM Corporation, GE Healthcare, Koninklijke Philips N.V., Agfa-Gevaert Group, Hyland Software Inc., Lexmark International Inc., Mach 7 Technologies Limited, Novarad Enterprise Healthcare Solutions, Reyence, Siemens (Siemens Healthcare Private Limited), Sectra AB, Softneta, SinoVision, TeleRAD Reporting Services Private Limited, and Voyager Imaging among others.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING DEMAND FOR EARLY DISEASE DETECTION
6.1.2 INCREASING IMAGING EQUIPMENT USAGE
6.1.3 THE PREVALENCE OF CHRONIC DISEASE AND PAIN-RELATED CONDITIONS
6.1.4 RISE IN BONE INJURIES AND ORTHOPEDIC CONDITIONS AND ITS IMAGING
6.2 RESTRAINTS
6.2.1 HIGH COSTS ASSOCIATED WITH THE IMPLEMENTATION OF MEDICAL IMAGING MANAGEMENT
6.2.2 STRINGENT REGULATORY REQUIREMENTS INVOLVED IN THE MANAGEMENT PROCESS
6.3 OPPORTUNITIES
6.3.1 ADOPTION OF AI TECHNOLOGY IN IMAGING
6.3.2 IMPROVEMENT IN GOVERNMENTAL STANDARDS AND POLICIES
6.3.3 ADVANCEMENTS IN RESEARCH AND DEVELOPMENT
6.4 CHALLENGES
6.4.1 DATA SECURITY AND PRIVACY CONCERNS DUE TO TECHNICAL COMPLEXITY
6.4.2 INCREASING IN THE INTEROPERABILITY ISSUES
7 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 TRADITIONAL PACS
7.2.1 IMAGE PROCESSING
7.2.2 IMAGE MANAGEMENT
7.3 SPECIALITY PACS
7.3.1 CARDIOLOGY PACS
7.3.2 ONCOLOGY PACS
7.3.3 PATHOLOGY PACS
7.3.4 ORTHOPEDIC PACS
7.3.5 DERMATOLOGY PACS
7.3.6 OPTHALMOLOGY PACS
7.3.7 DENTAL PACS
7.3.8 VETERINARY PACS
7.3.9 OTHERS
8 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COMPONENT
8.1 OVERVIEW
8.2 SOFTWARE
8.2.1 WEB/ CLOUD BASED
8.2.2 ON PREMISES
8.2.3 HYBRID
8.3 SERVICES
8.4 HARDWARE
9 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 MAGNETIC RESONANCE IMAGING (MRI)
9.3 COMPUTED TOMOGRAPHY (CT)
9.4 DIGITAL RADIOGRAPHY
9.5 ULTRASOUND
9.6 NUCLEAR IMAGING
9.7 C-ARMS
9.8 OTHERS
10 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL
10.1 OVERVIEW
10.2 INTEGRATED PACS
10.3 STANDALONE PACS
11 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 LARGE HOSPITALS
11.2.1.2 MEDIUM-SIZED HOSPITALS
11.2.1.3 SMALL HOSPITALS
11.3 RADIOLOGY CHAINS/ CENTERS
11.4 AMBULATORY SURGERY CENTERS
11.5 OTHERS
12 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDERS
12.3 THIRD PARTY ADMINISTRATORS
12.4 OTHERS
13 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COUNTRY
13.1 ASIA-PACIFIC
13.1.1 JAPAN
13.1.2 CHINA
13.1.3 AUSTRALIA
13.1.4 INDIA
13.1.5 SOUTH KOREA
13.1.6 SINGAPORE
13.1.7 MALAYSIA
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 VIETNAM
13.1.11 PHILIPPINES
13.1.12 REST OF ASIA-PACIFIC
14 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 FUJIFILM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENT
16.2 GE HEALTHCARE
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 KONINKLIJKE PHILIPS N.V.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 AGFA-GEVAERT GROUP.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 HYLAND SOFTWARE, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 PRODUCT PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 LEXMARK INTERNATIONAL, INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 MACH 7 TECHNOLOGIES LIMITED
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 NOVARAD ENTERPRISE HEALTHCARE SOLUTIONS
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 RAYENCE
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 SIEMENS (SIEMENS HEALTHCARE PRIVATE LIMITED)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 SECTRA AB
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 SOFTNETA
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 SINOVISION
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 TELERAD REPORTING SERVICES PRIVATE LIMITED
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 VOYAGER IMAGING
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC (APAC) TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC (APAC) IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC (APAC) SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC (APAC) CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC (APAC) ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC (APAC) ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC (APAC) DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC (APAC) OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC (APAC) VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC (APAC) TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 20 JAPAN DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 21 JAPAN TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 22 JAPAN IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 JAPAN SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 24 JAPAN CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 25 JAPAN ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 26 JAPAN ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 27 JAPAN DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 28 JAPAN OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 29 JAPAN DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 30 JAPAN VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 31 JAPAN DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 32 JAPAN SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 33 JAPAN DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 34 JAPAN DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 35 JAPAN DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 36 JAPAN HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 JAPAN DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 38 CHINA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 CHINA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 40 CHINA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 41 CHINA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 CHINA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 43 CHINA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 44 CHINA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 45 CHINA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 46 CHINA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 47 CHINA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 48 CHINA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 49 CHINA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 50 CHINA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 51 CHINA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 52 CHINA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 53 CHINA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 54 CHINA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 CHINA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 56 AUSTRALIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 AUSTRALIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 58 AUSTRALIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 AUSTRALIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 AUSTRALIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 61 AUSTRALIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 62 AUSTRALIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 63 AUSTRALIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 64 AUSTRALIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 65 AUSTRALIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 66 AUSTRALIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 67 AUSTRALIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 68 AUSTRALIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 AUSTRALIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 70 AUSTRALIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 71 AUSTRALIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 72 AUSTRALIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 AUSTRALIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 74 INDIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 INDIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 76 INDIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 INDIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 INDIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 79 INDIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 80 INDIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 81 INDIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 82 INDIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 83 INDIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 84 INDIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 85 INDIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 86 INDIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 INDIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 88 INDIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 89 INDIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 90 INDIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 91 INDIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 92 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 SOUTH KOREA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 94 SOUTH KOREA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 SOUTH KOREA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 SOUTH KOREA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 97 SOUTH KOREA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 98 SOUTH KOREA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 99 SOUTH KOREA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 100 SOUTH KOREA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 101 SOUTH KOREA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 102 SOUTH KOREA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 103 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 104 SOUTH KOREA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 106 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 107 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 108 SOUTH KOREA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 110 SINGAPORE DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 SINGAPORE TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 112 SINGAPORE IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 113 SINGAPORE SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 114 SINGAPORE CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 115 SINGAPORE ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 116 SINGAPORE ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 117 SINGAPORE DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 118 SINGAPORE OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 119 SINGAPORE DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 120 SINGAPORE VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 121 SINGAPORE DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 122 SINGAPORE SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 SINGAPORE DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 124 SINGAPORE DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 125 SINGAPORE DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 126 SINGAPORE HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 127 SINGAPORE DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 128 MALAYSIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 MALAYSIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 130 MALAYSIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 MALAYSIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 MALAYSIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 133 MALAYSIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 134 MALAYSIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 135 MALAYSIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 136 MALAYSIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 137 MALAYSIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 138 MALAYSIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 139 MALAYSIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 140 MALAYSIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 MALAYSIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 142 MALAYSIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 143 MALAYSIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 144 MALAYSIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 MALAYSIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 146 THAILAND DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 THAILAND TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 148 THAILAND IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 THAILAND SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 150 THAILAND CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 151 THAILAND ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 152 THAILAND ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 153 THAILAND DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 154 THAILAND OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 155 THAILAND DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 156 THAILAND VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 157 THAILAND DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 158 THAILAND SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 THAILAND DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 160 THAILAND DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 161 THAILAND DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 162 THAILAND HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 163 THAILAND DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 164 INDONESIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 INDONESIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 166 INDONESIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 INDONESIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 INDONESIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 169 INDONESIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 170 INDONESIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 171 INDONESIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 172 INDONESIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 173 INDONESIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 174 INDONESIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 175 INDONESIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 176 INDONESIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 INDONESIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 178 INDONESIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 179 INDONESIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 180 INDONESIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 INDONESIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 182 VIETNAM DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 VIETNAM TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 184 VIETNAM IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 VIETNAM SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 VIETNAM CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 187 VIETNAM ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 188 VIETNAM ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 189 VIETNAM DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 190 VIETNAM OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 191 VIETNAM DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 192 VIETNAM VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 193 VIETNAM DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 194 VIETNAM SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 VIETNAM DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 196 VIETNAM DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 197 VIETNAM DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 198 VIETNAM HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 VIETNAM DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 200 PHILIPPINES DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 201 PHILIPPINES TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 202 PHILIPPINES IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 PHILIPPINES SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 204 PHILIPPINES CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 205 PHILIPPINES ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 206 PHILIPPINES ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 207 PHILIPPINES DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 208 PHILIPPINES OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 209 PHILIPPINES DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 210 PHILIPPINES VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 211 PHILIPPINES DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 212 PHILIPPINES SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 213 PHILIPPINES DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 214 PHILIPPINES DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 215 PHILIPPINES DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 216 PHILIPPINES HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 PHILIPPINES DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 218 REST OF ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
Liste des figures
FIGURE 1 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: ASIA-PACIFIC VS REGIONS MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SEGMENTATION
FIGURE 11 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISION
FIGURE 14 RISING DEMAND FOR EARLY DISEASE DETECTION IS DRIVING THE GROWTH OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET FROM 2024 TO 2031
FIGURE 15 THE MIXERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, 2023
FIGURE 18 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 20 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, 2023
FIGURE 22 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, 2024-2031 (USD THOUSAND)
FIGURE 23 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, CAGR (2024-2031)
FIGURE 24 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, 2023
FIGURE 26 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 27 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, 2023
FIGURE 30 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, 2024-2031 (USD THOUSAND)
FIGURE 31 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, CAGR (2024-2031)
FIGURE 32 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: BY END USER 2023
FIGURE 34 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 35 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: END USER, CAGR (2024-2031)
FIGURE 36 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET END USER, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 38 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 39 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 40 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SNAPSHOT (2023)
FIGURE 42 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY SHARE 2023 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.